Dissemination of Carbapenem-resistant Klebsiella pneumoniae clinical isolates with various combinations of Carbapenemases (KPC-2, NDM-1, NDM-4, and OXA-48) and 16S rRNA Methylases (RmtB and RmtC) in Vietnam

BMC Infectious Diseases

Volumn 17, Issue 1, 2017, Pages

  Tada, Tatsuya ^a   Tsuchiya, Mitsuhiro ^a   Shimada, Kayo ^a   Nga, Tran Thi Thanh ^b   Thu, Le Thi Anh ^b   Phu, Truong Thien ^b   Ohmagari, Norio ^a   Kirikae, Teruo ^a,c  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b CHO RAY HOSPITAL   (Viet Nam)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Carbapenem resistant Klebsiella pneumoniae; Carbapenemase; MLST; Molecular epidemiology

Indexed keywords

AMIKACIN; CARBAPENEMASE; COLISTIN; HABEKACIN; IMIPENEM; MEROPENEM; RNA 16S; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; BETA-LACTAMASE KPC-2, KLEBSIELLA PNEUMONIAE; BETA-LACTAMASE NDM-1; CARBAPENEM DERIVATIVE; METHYLTRANSFERASE; RRNA (ADENOSINE-O-2'-)METHYLTRANSFERASE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; GENE IDENTIFICATION; KLEBSIELLA PNEUMONIAE; KPC 2 GENE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; MULTILOCUS SEQUENCE TYPING; NDM 1 GENE; NDM 4 GENE; NONHUMAN; OXA 48 GENE; PHYLOGENETIC TREE; RMTB GENE; RMTC GENE; SEQUENCE ALIGNMENT; SINGLE NUCLEOTIDE POLYMORPHISM; VIET NAM; WHOLE GENOME SEQUENCING; ANTIBIOTIC RESISTANCE; DRUG EFFECTS; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; PHYLOGENY;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; HUMANS; KLEBSIELLA PNEUMONIAE; METHYLTRANSFERASES; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; PHYLOGENY; VIETNAM;

EID: 85021631609     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-017-2570-y     Document Type: Article

References (21)

1. Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis. 2009 Apr;9(4):228-36.
2. Lee CR, Lee JH, Park KS, Kim YB, Jeong BC, Lee SH. Global dissemination of carbapenemase-producing Klebsiella pneumoniae: epidemiology, genetic context, treatment options, and detection methods. Front Microbiol. 2016 Jun 13;7:895.
3. Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2001 Apr;45(4):1151-61.
4. NDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 2009 Dec;53(12):5046-54.
5. Cornaglia G, Giamarellou H, Rossolini GM. Metallo-beta-lactamases: a last frontier for beta-lactams? Lancet Infect Dis. 2011 May;11(5):381-93.
6. Poirel L, Heritier C, Tolun V, Nordmann P. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother. 2004 Jan;48(1):15-22.
7. Wachino J, Yamane K, Shibayama K, Kurokawa H, Shibata N, Suzuki S, et al. Novel plasmid-mediated 16S rRNA methylase, RmtC, found in a Proteus mirabilis isolate demonstrating extraordinary high-level resistance against various aminoglycosides. Antimicrob Agents Chemother. 2006 Jan;50(1):178-84.
8. Tada T, Miyoshi-Akiyama T, Shimada K, Kirikae T. Biochemical analysis of the metallo-beta-lactamase NDM-3 from a multidrug-resistant Escherichia coli strain isolated in Japan. Antimicrob Agents Chemother. 2014 Mar;31
9. NDM-1 isolated from a patient in Rhode Island in 2012. Antimicrob Agents Chemother. 2013 Aug;57(8):4084-5.
10. Hoang TH, Wertheim H, Minh NB, Duong TN, Anh DD, Phuong TT, et al. Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae strains containing New Delhi metallo-β-lactamase isolated from two patients in Vietnam. J Clin Microbiol. 2013 Jan;51(1):373-4.
11. Nordmann P, Boulanger AE, Poirel L. NDM-4 metallo-beta-lactamase with increased carbapenemase activity from Escherichia coli. Antimicrob Agents Chemother. 2012 Apr;56(4):2184-6.
12. Papagiannitsis CC, Studentova V, Chudackova E, Bergerova T, Hrabak J, Radej J, et al. Identification of a New Delhi metallo-β-lactamase-4 (NDM-4)-producing Enterobacter cloacae from a Czech patient previously hospitalized in Sri Lanka. Folia Microbiol (Praha). 2013 Nov;58(6):547-9.
13. NDM-4 in Escherichia coli from hospital sewage. J Med Microbiol. 2014 Oct;63(Pt 10):1404-6.
14. Coppo E, Del Bono V, Ventura F, Camera M, Orengo G, Viscoli C, et al. Identification of a New Delhi metallo-β-lactamase-4 (NDM-4)-producing Escherichia coli in Italy. BMC Microbiol. 2014 Jun 7;14:148,2180-14-148.
15. Jakobsen L, Hammerum AM, Hansen F, Fuglsang-Damgaard D. An ST405 NDM-4-producing Escherichia coli isolated from a Danish patient previously hospitalized in Vietnam. J Antimicrob Chemother. 2014 Feb;69(2):559-60.
16. Khalifa HO, Soliman AM, Ahmed AM, Shimamoto T, Shimamoto T. NDM-4- and NDM-5-producing Klebsiella pneumoniae coinfection in a 6-month-old infant. Antimicrob Agents Chemother. 2016 Jun 20;60(7):4416-7.
17. Diancourt L, Passet V, Verhoef J, Grimont PA, Brisse S. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol. 2005 Aug;43(8):4178-82.
18. Breurec S, Guessennd N, Timinouni M, Le TA, Cao V, Ngandjio A, et al. Klebsiella pneumoniae Resistant to third-generation cephalosporins in five African and two Vietnamese major towns: Multiclonal population structure with two major international clonal groups, CG15 and CG258. Clin Microbiol Infect. 2013 Apr;19(4):349-55.
19. Pitout JD, Nordmann P, Poirel L. Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance. Antimicrob Agents Chemother. 2015 Oct;59(10):5873-84.
20. Nhung PH, Miyoshi-Akiyama T, Phuong DM, Shimada K, Anh NQ, Binh NG. Thanh do V, Ohmagari N, Kirikae T: evaluation of the Etest method for detecting colistin susceptibility of multidrug-resistant gram-negative isolates in Vietnam. J Infect Chemother. 2015;21(8):617-9.
21. Rojas LJ, Salim M, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Marshall S, Rudin SD, Domitrovic TN, Hujer AM, Hujer KM, Doi Y, Kaye KS, Evans S, Fowler VG Jr, Bonomo RA, van Duin D. Antibacterial resistance leadership group: Colistin resistance in Carbapenem-resistant Klebsiella pneumoniae: laboratory detection and impact on mortality. Clin Infect Dis. 2017;64(6):711-8.